Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01790503
Title A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Plexxikon
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern Memorial Hospital Chicago Illinois 60611 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Columbia University Medical Center New York New York 10032 United States Details
James Cancer Hospital/Ohio State University Columbia Ohio 43210 United States Details
Huntsman Cancer Institute University of Utah Salt Lake City Utah 84132 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field